Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tolerance of the Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05698459
What this trial is testing

OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer

Who this might be right for
Advanced Liver Cancer
Binhui Biopharmaceutical Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT02405013
What this trial is testing

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa

Who this might be right for
Hepatitis CHIV Infection
ANRS, Emerging Infectious Diseases 120
Post-approval studies (Phase 4)Study completedNCT00522730
What this trial is testing

Safety and Tolerance on Lipids of Parenteral and Enteral Nutrition in Critically Ill Patients With Liver Failure

Who this might be right for
Liver FailureCritical Illness
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 45
Not applicableLooking for participantsNCT06704321
What this trial is testing

Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Valbiotis 70
Not applicableEnrolling By InvitationNCT07445347
What this trial is testing

Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)Pulmonary HypertensionBevacizumab
Poitiers University Hospital 111
Early research (Phase 1)Looking for participantsNCT04587739
What this trial is testing

Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study.

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Lille 30
Not applicableStudy completedNCT00536250
What this trial is testing

Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth

Who this might be right for
Impaired Glucose TolerancePre-diabetesChildhood Obesity+2 more
Yale University 255
Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Not applicableEnrolling By InvitationNCT07735650
What this trial is testing

Immunosuppressant Withdrawal Based on Parenchymal Chimerism in the Liver Transplantation

Who this might be right for
Liver TransplantationLiver Transplantation in Long-term
Chang Gung Memorial Hospital 60
Early research (Phase 1)Study completedNCT02210182
What this trial is testing

A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Oncozyme Pharma Inc. 29
Testing effectiveness (Phase 2)UnknownNCT00438737
What this trial is testing

Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 100
Testing effectiveness (Phase 2)UnknownNCT04538313
What this trial is testing

A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs

Who this might be right for
Hepatic Carcinoma
CAR-T (Shanghai) Cell Biotechnology Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Not applicableEnded earlyNCT00585858
What this trial is testing

Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant

Who this might be right for
Kidney TransplantationLiver Transplantation
University of Wisconsin, Madison 15
Testing effectiveness (Phase 2)Study completedNCT02533180
What this trial is testing

Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation

Who this might be right for
Liver TransplantLiver Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableActive Not RecruitingNCT01047735
What this trial is testing

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObesity
University of Pittsburgh 69
Not applicableWithdrawnNCT05229640
What this trial is testing

Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis

Who this might be right for
CF - Cystic FibrosisCystic Fibrosis-related DiabetesCystic Fibrosis Liver Disease
Dartmouth-Hitchcock Medical Center
Early research (Phase 1)Ended earlyNCT01567540
What this trial is testing

A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Institut National de la Santé Et de la Recherche Médicale, France 3
Testing effectiveness (Phase 2)Study completedNCT00000654
What this trial is testing

The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU

Who this might be right for
Herpes SimplexHIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 78
Not applicableUnknownNCT01396954
What this trial is testing

Cirrhosis-Diabetes

Who this might be right for
Glucose Metabolism Disorders
Hospital Universitario Dr. Jose E. Gonzalez 130
Next Page